Cite

HARVARD Citation

    Brückl, D. et al. (2017). Efficacy and safety of erythrocytapheresis and low‐dose erythropoietin for treatment of hemochromatosis. Journal of clinical apheresis. 32 (3), pp. 170-174. [Online]. 
  
Back to record